News
Freshfields Advises PhenomeX in Its $108 Million Sale to Bruker
Freshfields advises PhenomeX, a functional cell biology company, in its agreement to sell to Bruker Corporation for $1.00 per share in an all-cash transaction. The proposed acquisition values PhenomeX at a total equity value of approximately $108 million. Learn more about the details of the transaction here.
The Freshfields deal team included M&A lawyers Damien Zoubek, Oliver Board, Brian Kloeblen and Clara Barnosky; executive compensation/benefits lawyers Brandon Gantus, Andrew Herman and Sonia Bennett; tax lawyers Joe Soltis and Brendan Counihan; IP and life sciences lawyer Vinita Kailasanath; IP lawyers Sora Park and Jake Silvers; leveraged finance lawyers Allison Liff, Meghan Bell and Nicholas Mack and antitrust lawyers Meghan Rissmiller, Ally Ampudia and Lauren Vaca.
About Freshfields Bruckhaus Deringer LLP
Freshfields Bruckhaus Deringer LLP is a global elite law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on groundbreaking and business-critical mandates. Our 2,800-plus lawyers deliver results worldwide through our own offices and alongside leading local firms. Our commitment, local and multinational expertise, and business know-how means our clients rely on us when it matters most.
Freshfields is ranked by Chambers Global in Band 1 across the six areas of antitrust, corporate/M&A, litigation, international arbitration, tax, and public international law. For more information visit Freshfields.us.
